These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3950582)

  • 21. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ; Foltzer M; Chapman S
    Virology; 1993 Jan; 192(1):132-41. PubMed ID: 8517015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice.
    Desprès P; Dietrich J; Girard M; Bouloy M
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2811-6. PubMed ID: 1834798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.
    Barrett AD; Pryde A; Medlen AR; Ledger TN; Whitby JE; Gibson CA; DeSilva M; Groves DJ; Langley DJ; Minor PD
    Vaccine; 1989 Aug; 7(4):333-6. PubMed ID: 2479185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.
    Pincus S; Mason PW; Konishi E; Fonseca BA; Shope RE; Rice CM; Paoletti E
    Virology; 1992 Mar; 187(1):290-7. PubMed ID: 1736531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).
    Lobigs M; Dalgarno L; Schlesinger JJ; Weir RC
    Virology; 1987 Dec; 161(2):474-8. PubMed ID: 2446422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pressure-inactivated yellow fever 17DD virus: implications for vaccine development.
    Gaspar LP; Mendes YS; Yamamura AM; Almeida LF; Caride E; Gonçalves RB; Silva JL; Oliveira AC; Galler R; Freire MS
    J Virol Methods; 2008 Jun; 150(1-2):57-62. PubMed ID: 18420285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.
    Putnak JR; Schlesinger JJ
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1697-702. PubMed ID: 2144016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope.
    Lu X; Xiao H; Li S; Pang X; Song J; Liu S; Cheng H; Li Y; Wang X; Huang C; Guo T; Ter Meulen J; Daffis S; Yan J; Dai L; Rao Z; Klenk HD; Qi J; Shi Y; Gao GF
    Cell Rep; 2019 Jan; 26(2):438-446.e5. PubMed ID: 30625326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune enhancement of yellow fever virus neurovirulence for mice: studies of mechanisms involved.
    Gould EA; Buckley A; Groeger BK; Cane PA; Doenhoff M
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3105-12. PubMed ID: 3694178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1.
    Schlesinger JJ; Brandriss MW; Cropp CB; Monath TP
    J Virol; 1986 Dec; 60(3):1153-5. PubMed ID: 3783816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus.
    Sil BK; Dunster LM; Ledger TN; Wills MR; Minor PD; Barrett AD
    J Virol; 1992 Jul; 66(7):4265-70. PubMed ID: 1376368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies identify the NS5 yellow fever virus non-structural protein in the nuclei of infected cells.
    Buckley A; Gaidamovich S; Turchinskaya A; Gould EA
    J Gen Virol; 1992 May; 73 ( Pt 5)():1125-30. PubMed ID: 1534119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
    Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
    Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection of mice against experimental Japanese encephalitis virus infections by neutralizing anti-glycoprotein E monoclonal antibodies.
    Gupta AK; Lad VJ; Koshy AA
    Acta Virol; 2003; 47(3):141-5. PubMed ID: 14658841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies.
    Czerny CP; Mahnel H
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2341-52. PubMed ID: 1700065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.